Christine L. Bui, MPH

Director, Epidemiology
RTI-HS
Research Triangle Park, United States

Disclosure information not submitted.

Presentation(s):

• Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States

  Tuesday, August 27, 2024
  9:15 AM – 9:30 AM CEST

• Events on Day Zero of Follow-Up: Considerations for Cohort Studies of Adverse Events After COVID-19 Diagnosis

  Tuesday, August 27, 2024
  1:00 PM – 1:15 PM CEST

• Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  1:30 PM – 1:45 PM CEST

• Risk of Cardiovascular Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  2:45 PM – 3:00 PM CEST